Spirometry, Rapid FEV₁ Decline, and Lung Cancer Among Asbestos Exposed Heavy Smokers

REFERENCES

• Pauwels R A, Buist A S, Calverley P M, Jenkins C R, Hurd S S. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary (Review). Am J Respir Crit Care Med 2001; 163: 1256–1276
   PubMedGoogle Scholar
• Burrows B. Predictors of loss of lung function and mortality in obstructive lung disease. Eur Respir Rev 1991; 1: 340–345
   Google Scholar
• Mayne S T, Buenconsejo J, Janerich D T. Previous lung disease and risk of lung cancer among men and women nonsmokers. Am J Epidemiol 1999; 149: 13–20
   PubMed Web of Science ®Google Scholar
• Papi A, Casoni G, Caramori G, Guzzinati I, Boschetto P, Ravenna F, Calia N, Petruzzelli S, Corbetta L, Cavallesco G, Forini E, Saetta M, Ciaccia A, Fabbri L M. COPD increases the risk of squamous histological subtype in smokers who develop non-small cell lung carcinoma. Thorax 2004; 59: 679–681
   PubMed Web of Science ®Google Scholar
• Eberly L E, Ockene J, Sherwin R, Yang L, Kuller L. Multiple Risk Factor Intervention Trial Research Group. Pulmonary function as a predictor of lung cancer mortality in continuing cigarette smokers and in quitters. Int J Epidemiol 2003; 32: 592–599
   PubMed Web of Science ®Google Scholar
• Cullen M R, Barnett M J, Balmes J R, Cartmel B, Redlich C A, Brodkin C A, Barnhart S, Rosenstock L, Goodman G E, Hammar S P, Thornquist M D, Omenn G S. Predictors of lung cancer among asbestos-exposed men in the beta-carotene and retinol efficacy trial. Am J Epidemiol 2005; 161: 260–270
   PubMed Web of Science ®Google Scholar
• Omenn G S, Goodman G E, Thornquist M D, Balmes J, Cullen M R, Glass A, Keogh J P, Meyskens F L, Valanis B, Williams J H, Barnhart S, Hammar S. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996; 334: 1150–1155
   PubMed Web of Science ®Google Scholar
• Goodman G E, Omenn G S, Thornquist M D, Lund B, Metch B, Gylys-Colwell I. The Carotene and Retinol Efficacy Trial (CARET) to prevent lung cancer in high-risk populations: pilot study with cigarette smokers. Cancer Epidemiol Biomarkers Prev 1993; 2: 389–396
   PubMed Web of Science ®Google Scholar
• Barnhart S, Keogh J, Cullen M R, Brodkin C, Liu D, Goodman G, Valanis B, Glass A, Thornquist M, Rosenstock L, Omenn G, Balmes J. The CARET asbestos-exposed cohort: baseline characteristics and comparison to other asbestos-exposed cohorts. Am J Ind Med 1997; 32: 573–581
   PubMed Web of Science ®Google Scholar
• Crapo R O, Morris A H, Gardner R M. Reference spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis 1981; 123: 659–664
   PubMed Web of Science ®Google Scholar
• Fletcher C M, Peto R, Tinker C, Speizer F E. An Eight-Year Study of Early Chronic Obstructive Lung Disease in Working Men in London. The Natural History of Chronic Bronchitis and Emphysema. Oxford University Press, Oxford 1976
   Google Scholar
• Sorlie P D, Kannel W B. O'Connor G. Mortality associated with respiratory function and symptoms in advanced age. The Framingham Study. Am Rev Respir Dis 1989; 140: 379–384
   PubMed Web of Science ®Google Scholar
• Enright R L, Connett J E, Bailey W C. The FEV1/FEV6 predicts lung function decline in adult smokers. Respir Med 2002; 96: 444–449
   PubMed Web of Science ®Google Scholar
• Anthonisen N R, Connett J E, Kiley J P, Altose M D, Bailey W C, Buist A S, Conway W AJ, Enright P L, Kanner R E, O'Hara P. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. J Am Med Assoc 1994; 272: 1497–1505
   PubMed Web of Science ®Google Scholar
• Wasswa-Kintu S, Gan W Q, Man S F, Pare P D, Sin D D. Relationship between reduced forced expiratory volume in one second and the risk of lung cancer: a systematic review and meta-analysis. Thorax 2005; 60: 570–575
   PubMed Web of Science ®Google Scholar
• Rutgers S R, Postma D S, ten Hacken N H, Kauffman H F, van Der Mark T W, Koeter G H, Timens W. Ongoing airway inflammation in patients with COPD who do not currently smoke. Thorax 2000; 55: 12–18
   PubMed Web of Science ®Google Scholar
• Maestrelli P, Saetta M, Di Stefano A, Calcagni P G, Turato G, Ruggieri M P, Roggeri A, Mapp C E, Fabbri L M. Comparison of leukocyte counts in sputum, bronchial biopsies, and bronchoalveolar lavage. Am J Respir Crit Care Med 1995; 152: 1926–1931
   PubMed Web of Science ®Google Scholar
• Thompson A B, Daughton D, Robbins R A, Ghafouri M A, Oehlerking M, Rennard S I. Intraluminal airway inflammation in chronic bronchitis. Characterization and correlation with clinical parameters. Am Rev Respir Dis 1989; 140: 1527–1537
   PubMed Web of Science ®Google Scholar
• Hogg J C, Chu F, Utokaparch S, Woods R, Elliott W M, Buzatu L, Cherniack R M, Rogers R M, Sciurba F C, Coxson H O, Pare P D. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004; 350: 2645–2653
   PubMed Web of Science ®Google Scholar
• de Visser K E, Coussens L M. The interplay between innate and adaptive immunity regulates cancer development. Cancer Immunol Immunother 2005; 54: 1143–1152
   PubMed Web of Science ®Google Scholar
• Kocazeybek B. Chronic Chlamydophila pneumoniae infection in lung cancer, a risk factor: a case-control study. J Med Microbiol 2003; 52: 721–726
   PubMed Web of Science ®Google Scholar
• Anttila T, Koskela P, Leinonen M, Laukkanen P, Hakulinen T, Lehtinen M, Pukkala E, Paavonen J, Saikku P. Chlamydia pneumoniae infection and the risk of female early-onset lung cancer. Int J Cancer 2003; 107: 681–682
   PubMed Web of Science ®Google Scholar
• Littman A J, White E, Jackson L A, Thornquist M D, Gaydos C A, Goodman G E, Vaughan T L. Chlamydia pneumoniae infection and risk of lung cancer. Cancer Epidemiol Biomarkers Prev 2004; 13: 1624–1630
   PubMed Web of Science ®Google Scholar
• Celli B R, Halbert R J, Nordyke R J, Schau B. Airway obstruction in never smokers: results from the Third National Health and Nutrition Examination Survey. Am J Med 2005; 118: 1364–1372
   PubMed Web of Science ®Google Scholar
• Wilk J B, Djousse L, Arnett D K, Rich S S, Province M A, Hunt S C, Crapo R O, Higgins M, Myers R H. Evidence for major genes influencing pulmonary function in the NHLBI family heart study. Genet Epidemiol 2000; 19: 81–94
   PubMed Web of Science ®Google Scholar
• American Thoracic Society. Diagnosis and initial management of nonmalignant diseases related to asbestos. Am J Respir Crit Care Med 2004; 170: 691–715
   PubMed Web of Science ®Google Scholar
• Ohar J, Sterling D A, Bleecker E, Donohue J. Changing patterns in asbestos-induced lung disease. Chest 2004; 125: 744–753
   PubMed Web of Science ®Google Scholar
• Gan W Q, Man S F, Postma D S, Camp P, Sin D D. Female smokers beyond the perimenopausal period are at increased risk of chronic obstructive pulmonary disease: a systematic review and meta-analysis. Respir Res 2006; 7: 52
   PubMed Web of Science ®Google Scholar
• Loganathan R S, Stover D E, Shi W, Venkatraman E. Prevalence of COPD in women compared to men around the time of diagnosis of primary lung cancer. Chest 2006; 129: 1305–1312
   PubMed Web of Science ®Google Scholar
• Stratelis G, Molstad S, Jakobsson P, Zetterstrom O. 2006 ABS88: Diagnosis of COPD combined with brief smoking cessation advice increases smoking cessation rate in comparison with those with normal lung function. Prim Care Respir J 2006, May 20; [Epub ahead of print]
   Google Scholar